Usfda News

Alembic Pharmaceuticals announced that its Vadodara facility successfully cleared a USFDA inspection with zero observations, indicating the facility's commitmen

Pharmaceutical company Lupin has received USFDA approval for its Modafinil tablets, intended to treat excessive sleepiness in adults. The drug is bioequivalent

Aurobindo Pharma announced that the US Food and Drug Administration (USFDA) concluded its routine inspection of its subsidiary Lannett Company LLC's facility in

Aurobindo Pharma's wholly owned US subsidiary, Lannett Company LLC, received four observations from the USFDA following a routine inspection conducted from Augu

Biocon shares increased by 2% following the USFDA's supplemental approval for its subsidiary's Yesintek single-dose prefilled autoinjectors. This approval expan

Lupin received USFDA approval for generic Pitolisant Tablets, enhancing its US portfolio and specialty generics presence. Despite this positive regulatory news,

Aurobindo Pharma's subsidiary, Eugia Pharma, received a warning letter from the USFDA following an inspection of its Telangana formulation manufacturing facilit

अमेरिकी स्वास्थ्य नियामक यूएस फूड एंड ड्रग एडमिनिस्ट्रेशन (यूएसएफडीए) ने डाबर इंडिया को सिलवासा स्थित उसके दवा निर्माण संयंत्र में करंट गुड मैन्युफैक्चरिंग प्रै

Gland Pharma has received USFDA approval for its generic version of sugammadex injection, a drug used to reverse muscle relaxant effects during surgery. The app

Alembic Pharmaceuticals has received final USFDA approval for its generic prucalopride tablets, indicated for chronic idiopathic constipation, which are therape

Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for generic Olaparib tablets, a cancer drug with an estimated US market size of